Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl Citrate Buccal Tablets for Cancer Breakthrough Pain
CTR20222298Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough cancer pain (BTcP), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Sep 2022; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on CTR20222298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222298.